Categories Uncategorized

Pure Extract Technologies Inc. Ideally Positioned to Become Leader in White Label Market

  • Company’s Standard Processing License pending approval from Health Canada
  • After licensing approval, Pure Extracts will be launching white label production as part of core services
  • Pure Extracts facility designed to produce high-quality, high-purity formulations on a commercial scale

Pure Extract Technologies, a Canadian plant-based extraction company operating in the functional medicinal mushrooms space, is preparing to become a leading contender in the white labeling space. The Company’s Standard Processing License is currently pending approval from Health Canada; upon approval the Company will be launching whiteproduction as part of its core services.

As an expert in the extraction field, Pure Extracts provides white label solutions based on custom formulating high-quality oils sourced from both cannabis and hemp-biomass products. In addition, the Company offers impressive expertise in designing and manufacturing consumer-ready packaging for customers.

White label products, which are products made by one company and then packaged and sold by other companies under various brand names, can provide substantial time, energy and financial savings in terms of production and marketing (http://ibn.fm/7KVnv). The practice has been steadily growing and often allows a company to offer quality products that they would otherwise be unable to provide.

As a leading extraction company, Pure Extracts is able to rapidly develop and commercialize extraction systems for plant-based medicine products. The Company has a centralized 10,000-square-foot facility built to EU-GMP standards and designed for proprietary and white label production; the facility is located in Pemberton, British Columbia. A phase 2 plan currently under development will expand the facility to 25,000 square feet and build it to EU-GMP standards, allowing the Pure Extracts to offer international distribution.

Designed with future growth in mind, the facility includes a dedicated lab that provides invaluable research and development services, is easily scalable, and offers modern CO2 and ethanol extraction capabilities and processes. The Company is designed to produce high-quality, high-purity formulations on a commercial scale.

In short, for companies licensed to sell specialized oil extracts and for CPG brands seeking licensed manufacturing partners, Pure Extracts offers a one-stop solution that ensures expert production and manufacturing resulting in top-quality products.

Pure Extracts is positioned to enter the commercial cannabis sector as an experienced producer. Led by a team of qualified experts in the space and providing cutting-edge CO2 and ethanol extraction technology, the Company is set up for long-term strategic distribution and product innovation.

For more information, visit the company’s website at www.PureExtractsCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts are available in the company’s newsroom at http://ibn.fm/Pure

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Chris@PNW

Share
Published by
Chris@PNW

Recent Posts

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Files Abbreviated New Drug Application for Preservative-Free IV Ketamine NRX-100 Amid Ongoing Shortage

The company targets all current ketamine indications, including anesthesia and pain management. The U.S. is…

4 days ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network

The Kadima Neuropsychiatry Institute acquisition is part of NRx subsidiary HOPE Therapeutics’ model for a…

1 week ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Announces $10.3 Million Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval

Subsidiary HOPE Therapeutics signed a $7.8 million debt financing term sheet with Universal Capital. Combined…

3 weeks ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute Acquisition

Kadima Neuropsychiatry Institute is expected to become the clinical model for HOPE Therapeutics’ nationwide network…

3 weeks ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Is ‘One to Watch’

NRx Pharmaceuticals is advancing a pipeline of innovative therapies targeting multibillion-dollar unmet needs in central…

4 weeks ago

Republican Lawmakers Embrace Psychedelic Therapies in Shift Toward Veteran Mental Health Reform

Rep. Morgan Luttrell (R-Texas), a retired Navy SEAL, is part of a rising wave of…

4 weeks ago